If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

4 Nov 2014 07:00

RNS Number : 0309W
Biome Technologies PLC
04 November 2014
 



04 November 2014

 

 

Biome Technologies plc ("Biome", "the Company" or "the Group")

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes a trading update for the nine months ended 30 September 2014.

 

Total Group revenues achieved for the third quarter were £0.5m (Q3 2013: £0.6m) taking Group revenues for the nine months to 30 September 2014 to £2.8m, 85% ahead of the same period in 2013 (2013: £1.5m). The Group's cash position as at 30 September 2014 was £2.8m (30 June 2014: £3.1m).

Bioplastics Division

Revenues for the Bioplastics division in Q3 were £0.1m (Q3 2013: £0.4m), down substantially on the previous two quarters. Offtake reduced to the single-serve coffee market in the USA as the main customer responded to technical challenges in the market place and ran down stocks ahead of re-launches. The Board believes that these effects are temporary and that revenue growth will resume in the near future.

Further progress was made in the development of the pipeline of new bioplastic polymers with technical and customer trials continuing in both the food service and paper-board coating sectors. The business launched a new product in September, formulated to improve both speed and performance in 3D printing applications, whilst retaining impeccable environmental credentials. This is the division's first foray into this emerging sector and initial response from end-use customers is encouraging.

Earlier in the year, the division announced the successful completion of a feasibility study undertaken in conjunction with the University of Warwick and supported by Innovate UK (formerly the Technology Strategy Board). This study examined the feasibility of producing a bacterially derived lignin-based alternative to the oil-based chemicals used in the manufacture of bioplastics. The Board is exploring options for further scale-up of this technology and is awaiting the result of a further grant application to Innovate UK. The result of this application is expected in the near future.

 

Stanelco RF Technologies Division

Revenues for the RF division remained firm at £0.4m (Q3 2013: £0.2m). Demand from the optical fibre furnace market in Asia continues to underpin revenues whilst products for a broader portfolio of market applications are progressing well. The unit's order-book into 2015 is robust and recruitment has been recently completed to extend both capacity and capability.

 

Outlook

The Board remains confident of meeting market expectations for the year.

 

-Ends-

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Daniel Stewart & Company plc

Paul Shackleton (Nominated Adviser)

Mark Treharne (Broker)

www.danielstewart.co.uk

Tel: +44 (0) 20 7776 6550

Allenby Capital

Chris Crawford/Kelly Gardiner

www.allenbycapital.com

Tel: +44 (0) 20 3002 2070

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQKNDBABDDPDK
Date   Source Headline
2nd Jul 20087:00 amRNSTotal Voting Rights
16th Jun 20082:56 pmRNSHolding(s) in Company
16th Jun 20087:00 amRNSHolding(s) in Company
10th Jun 20085:36 pmRNSHolding(s) in Company
4th Jun 20087:00 amRNSAdditional Listing
14th May 20088:53 amRNSDirector/PDMR Shareholding
7th May 20089:51 amRNSDirectors Dealing
7th May 20087:00 amRNSLicense Agreement
1st May 20085:27 pmRNSDirector's Dealings
28th Apr 200811:56 amRNSResult of AGM
28th Apr 20087:00 amRNSAGM and IMS
25th Apr 20083:06 pmRNSDirector/PDMR Shareholding
7th Apr 20084:41 pmRNSSecond Price Monitoring Extn
7th Apr 20084:35 pmRNSPrice Monitoring Extension
7th Apr 20087:00 amRNSAnnual Information Update
2nd Apr 20087:00 amRNSPosting of Annual Report
14th Mar 20087:01 amRNSPreliminary Results
6th Mar 20082:35 pmRNSHolding(s) in Company
3rd Mar 20085:21 pmRNSHolding(s) in Company
29th Feb 20089:43 amRNSSpeculation re plastics
18th Feb 20084:40 pmRNSSecond Price Monitoring Extn
18th Feb 20084:35 pmRNSPrice Monitoring Extension
7th Feb 20084:13 pmRNSNotifiable Interest
4th Feb 200810:25 amRNSHolding(s) in Company
1st Feb 200811:40 amRNSHolding(s) in Company
30th Jan 20084:20 pmRNSNotifiable Interest
30th Jan 20087:01 amRNSNotifiable Interest
28th Jan 200811:22 amRNSNotifiable Interest
21st Jan 20083:27 pmRNSNotifiable Interest
17th Jan 20083:40 pmRNSNotifiable Interest
15th Jan 20084:40 pmRNSSecond Price Monitoring Extn
15th Jan 20084:35 pmRNSPrice Monitoring Extension
15th Jan 20082:28 pmRNSNotifiable Interest
14th Jan 20087:00 amRNSPre Close Update
9th Jan 20084:25 pmRNSHolding(s) in Company
4th Dec 20074:40 pmRNSSecond Price Monitoring Extn
4th Dec 20074:35 pmRNSPrice Monitoring Extension
26th Nov 20074:35 pmRNSPrice Monitoring Extension
25th Sep 20079:54 amRNSNotifiable Interest
10th Sep 20077:02 amRNSInterim Results
28th Aug 20072:33 pmRNSNotifiable Interest
30th Jul 20074:37 pmRNSNotifiable Interest
30th Jul 20074:35 pmRNSNotifiable Interest
27th Jul 20071:56 pmRNSNotifiable Interest
6th Jul 20077:01 amRNSTrading Statement
5th Jul 20076:19 pmRNSDirector Dealings
29th Jun 200712:26 pmRNSTotal Voting Rights
6th Jun 20074:14 pmRNSAdditional Listing
29th May 20075:29 pmRNSDisposal of Assets
29th May 20077:02 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.